Qiagen N.V.

Equities

QGEN

NL0015002SN0

Market Closed - Nyse Other stock markets 04:00:02 2026-04-16 pm EDT			5-day change	1st Jan Change
40.96 ^USD	-1.63%		-0.12%	-13.47%

Apr. 14	Qiagen Expands Into Bloodstream Infection Testing With New Panel	MT
Apr. 14	Qiagen N.V. Expands into Bloodstream Infection Syndromic Testing with New Rapid QIAstat-Dx Panel	CI

Transcript : Qiagen N.V. Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09

Published on 03/02/2026 at 11:35 am EST - Modified on 04/10/2026 at 09:10 pm EDT

S&P Capital IQ

Presenter Speech
Daniel Brennan (Analysts)

Welcome. Good morning. Dan Brennan from TD Cowen Tools and Diagnostics team. Pleased to be joining here, kicking off the 46th Annual TD Cowen Healthcare

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Qiagen N.V.

Apr. 14	Qiagen Expands Into Bloodstream Infection Testing With New Panel	MT
Apr. 14	Qiagen N.V. Expands into Bloodstream Infection Syndromic Testing with New Rapid QIAstat-Dx Panel	CI
Apr. 14	QIAGEN NV : Barclays is less optimistic	ZD
Apr. 14	Barclays Downgrades QIAGEN to Equalweight From Overweight, Adjusts Price Target to $44 From $48	MT
Apr. 01	Bruker Corporation Announces Appointment of Thierry L. Bernard to Its Board of Directors, Effective April 1, 2026	CI
Mar. 30	AlphaValue/Baader Europe Upgrades Qiagen to Buy	MT
Mar. 19	Qiagen N.V. Highlights Newly Published Data Supporting Efficacy of QuantiFERON for Tb Prevention	CI
Mar. 13	Frankfurt Market Close: Dax continues to slide - Risk aversion persists amid oil concerns	DP
Mar. 13	Wall Street Clings to Hope
Mar. 13	Deutsche Bank Upgrades Qiagen to Buy Rating, Lifts PT	MT
Mar. 13	Analyst recommendations: Adobe, Oracle, Dow, Him & Hers, Whirlpool…
Mar. 13	QIAGEN NV : Upgraded to Buy by Deutsche Bank	ZD
Mar. 11	Qiagen receives U.S. clearance for gastrointestinal panels on fully automated Qiastat-Dx Rise syndromic testing system	RE
Mar. 10	QIAGEN Gets US FDA Clearance for Gastrointestinal Panels on Automated Syndromic Platform	MT
Mar. 10	Qiagen N.V. Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated Qiastat-Dx Rise Syndromic Testing System	CI